Literature DB >> 27789499

Bad Medicine: The rise and rise of antidepressants.

Des Spence1.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27789499      PMCID： PMC5072904          DOI： 10.3399/bjgp16X687793

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  7 in total

Review 1.  Lessons learned from placebo groups in antidepressant trials.

Authors:  Meike Shedden Mora; Yvonne Nestoriuc; Winfried Rief
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-06-27       Impact factor: 6.237

Review 2.  Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review.

Authors:  John R Geddes; Stuart M Carney; Christina Davies; Toshiaki A Furukawa; David J Kupfer; Ellen Frank; Guy M Goodwin
Journal:  Lancet       Date:  2003-02-22       Impact factor: 79.321

Review 3.  Selective serotonin reuptake inhibitors for unipolar depression: a systematic review of classic long-term randomized controlled trials.

Authors:  Dorian Deshauer; David Moher; Dean Fergusson; Ester Moher; Margaret Sampson; Jeremy Grimshaw
Journal:  CMAJ       Date:  2008-05-06       Impact factor: 8.262

Review 4.  Antidepressant drug effects and depression severity: a patient-level meta-analysis.

Authors:  Jay C Fournier; Robert J DeRubeis; Steven D Hollon; Sona Dimidjian; Jay D Amsterdam; Richard C Shelton; Jan Fawcett
Journal:  JAMA       Date:  2010-01-06       Impact factor: 56.272

Review 5.  Antidepressants versus placebo for depression in primary care.

Authors:  Bruce Arroll; C Raina Elley; Tana Fishman; Felicity A Goodyear-Smith; Tim Kenealy; Grant Blashki; Ngaire Kerse; Stephen Macgillivray
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

Review 6.  Serotonin and depression: a disconnect between the advertisements and the scientific literature.

Authors:  Jeffrey R Lacasse; Jonathan Leo
Journal:  PLoS Med       Date:  2005-11-08       Impact factor: 11.069

7.  Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration.

Authors:  Irving Kirsch; Brett J Deacon; Tania B Huedo-Medina; Alan Scoboria; Thomas J Moore; Blair T Johnson
Journal:  PLoS Med       Date:  2008-02       Impact factor: 11.069
  7 in total
  3 in total

1.  Bad Medicine: The medical untouchables.

Authors:  Des Spence
Journal:  Br J Gen Pract       Date:  2017-08       Impact factor: 5.386

2.  An examination of the medicalization and pharmaceuticalization processes of anxiety and depressive disorders in Belgium between 2004 and 2013: how may both disorders be intertwined?

Authors:  Van Looy Kilian; Van de Velde Sarah
Journal:  Arch Public Health       Date:  2022-08-15

3.  An analysis of antidepressant prescribing trends in England 2015-2019.

Authors:  Hasnain M Lalji; Anita McGrogan; Sarah J Bailey
Journal:  J Affect Disord Rep       Date:  2021-08-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.